We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
47 hedge funds and large institutions have $200M invested in Evelo Biosciences, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
188% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 8
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
85% more capital invested
Capital invested by funds: $108M → $200M (+$91.9M)
12% more funds holding
Funds holding: 42 → 47 (+5)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
47
Holders Change
+5
Holders Change %
+11.9%
% of All Funds
0.96%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
23
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$20.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.82M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$5.69M |
| 4 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$5.69M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$5.47M |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$668K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$284K |
| 3 |
Bank of New York Mellon
New York
|
-$41.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$18.4K |
